Literature DB >> 30591730

Anticancer drugs: Cutting down on prostate cancer metastases.

Megan Cully.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30591730     DOI: 10.1038/nrd.2018.225

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis.

Authors:  Mirja Rotinen; Sungyong You; Julie Yang; Simon G Coetzee; Mariana Reis-Sobreiro; Wen-Chin Huang; Fangjin Huang; Xinlei Pan; Alberto Yáñez; Dennis J Hazelett; Chia-Yi Chu; Kenneth Steadman; Colm M Morrissey; Peter S Nelson; Eva Corey; Leland W K Chung; Stephen J Freedland; Dolores Di Vizio; Isla P Garraway; Ramachandran Murali; Beatrice S Knudsen; Michael R Freeman
Journal:  Nat Med       Date:  2018-11-26       Impact factor: 53.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.